These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1930322)

  • 1. Allopurinol sensitivity in a patient with chronic tophaceous gout: success of intravenous desensitization after failure of oral desensitization.
    Walz-LeBlanc BA; Reynolds WJ; MacFadden DK
    Arthritis Rheum; 1991 Oct; 34(10):1329-31. PubMed ID: 1930322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral desensitization in patients with chronic tophaceous gout and allopurinol hypersensitivity.
    Gillott TJ; Whallett A; Zaphiropoulos G
    Rheumatology (Oxford); 1999 Jan; 38(1):85-6. PubMed ID: 10334688
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous desensitization to allopurinol in a heart transplant patient with gout.
    Schumacher MJ; Copeland JG
    Ann Allergy Asthma Immunol; 2004 Mar; 92(3):374-6. PubMed ID: 15049403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allopurinol hypersensitivity in a patient with severe, chronic, tophaceous gout.
    Webster E; Panush RS
    Arthritis Rheum; 1985 Jun; 28(6):707-9. PubMed ID: 4004980
    [No Abstract]   [Full Text] [Related]  

  • 5. Desensitization to allopurinol in a patient with previous failed desensitization.
    Tanna SB; Barnes JF; Seth SK
    Ann Pharmacother; 1999 Nov; 33(11):1180-3. PubMed ID: 10573316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitization to allopurinol in patients with gout and cutaneous reactions.
    Fam AG; Lewtas J; Stein J; Paton TW
    Am J Med; 1992 Sep; 93(3):299-302. PubMed ID: 1388001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid oral allopurinol desensitization in a patient with chronic myeloid leukemia.
    Toker O; Tvito A; Rowe JM; Ashkenazi J; Ganzel C; Tal Y; Shalit M
    Isr Med Assoc J; 2014 Jul; 16(7):461-2. PubMed ID: 25167698
    [No Abstract]   [Full Text] [Related]  

  • 8. Desensitisation in a patient with chronic renal disease and severe allergy to allopurinol.
    Meyrier A
    Br Med J; 1976 Aug; 2(6033):458. PubMed ID: 953607
    [No Abstract]   [Full Text] [Related]  

  • 9. Allopurinol hypersensitivity reactions: desensitization strategies and new therapeutic alternative molecules.
    Calogiuri G; Nettis E; Di Leo E; Foti C; Ferrannini A; Butani L
    Inflamm Allergy Drug Targets; 2013 Feb; 12(1):19-28. PubMed ID: 23092365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful desensitisation of allopurinol-induced erythema multiforme.
    Fonseka MM; Sathischandra H; Jayamanne SF; de Silva HJ
    Ceylon Med J; 1999 Dec; 44(4):190-1. PubMed ID: 10895280
    [No Abstract]   [Full Text] [Related]  

  • 11. Allopurinol-associated hand and foot deformities in chronic tophaceous gout.
    Gottlieb NL; Gray RG
    JAMA; 1977 Oct; 238(15):1663-4. PubMed ID: 578255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful desensitization of a fixed drug eruption caused by allopurinol.
    Umpiérrez A; Cuesta-Herranz J; De Las Heras M; Lluch-Bernal M; Figueredo E; Sastre J
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):286-7. PubMed ID: 9500766
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacologic desensitization by intravenous protocols.
    Steinberg DG; Borish LC; Rosenwasser LJ
    Arthritis Rheum; 1992 Jul; 35(7):842-3. PubMed ID: 1622426
    [No Abstract]   [Full Text] [Related]  

  • 14. How should we treat tophaceous gout in patients with allopurinol hypersensitivity?
    Grahame R; Simmonds HA; McBride MB; Marsh FP
    Adv Exp Med Biol; 1998; 431():19-23. PubMed ID: 9598024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How should hyperuricemia be treated in a patient with allopurinol hypersensitivity?
    Monev SD
    Cleve Clin J Med; 2001 Jul; 68(7):597-8. PubMed ID: 11453075
    [No Abstract]   [Full Text] [Related]  

  • 16. Allopurinol hypersensitivity in a patient with coexistent systemic lupus erythematosus and tophaceous gout.
    McDonald J; Fam AG; Paton T; Senn J
    J Rheumatol; 1988; 15(5):865-8. PubMed ID: 3172103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rush desensitization to allopurynol.
    Nitti F; Fumagalli M; Incorvaia C
    Allergy; 2003 Jul; 58(7):690. PubMed ID: 12823143
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic alternatives in a patient with DRESS syndrome induced by allopurinol.
    Calogiuri GF; Satriano F; Muratore L; Valacca A; Nettis E; Di Leo E; Vacca A
    J Investig Allergol Clin Immunol; 2009; 19(4):333-4. PubMed ID: 19639739
    [No Abstract]   [Full Text] [Related]  

  • 19. Allopurinol Desensitization: A Fast or Slow Protocol?
    Soares J; Caiado J; Lopes A; Pereira BM
    J Investig Allergol Clin Immunol; 2015; 25(4):295-7. PubMed ID: 26310045
    [No Abstract]   [Full Text] [Related]  

  • 20. How to prevent allopurinol hypersensitivity reactions?
    Stamp LK; Barclay ML
    Rheumatology (Oxford); 2018 Jan; 57(suppl_1):i35-i41. PubMed ID: 29272508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.